92 related articles for article (PubMed ID: 9796973)
21. Expression of cadherin-8 in renal cell carcinoma and fetal kidney.
Blaschke S; Mueller CA; Markovic-Lipkovski J; Puch S; Miosge N; Becker V; Mueller GA; Klein G
Int J Cancer; 2002 Oct; 101(4):327-34. PubMed ID: 12209956
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma.
Ronkainen H; Kauppila S; Hirvikoski P; Vaarala MH
J Exp Clin Cancer Res; 2010 Jan; 29(1):2. PubMed ID: 20074327
[TBL] [Abstract][Full Text] [Related]
23. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
24. Cadherin-9 is a novel cell surface marker for the heterogeneous pool of renal fibroblasts.
Thedieck C; Kalbacher H; Kuczyk M; Müller GA; Müller CA; Klein G
PLoS One; 2007 Aug; 2(7):e657. PubMed ID: 17668045
[TBL] [Abstract][Full Text] [Related]
25. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
[TBL] [Abstract][Full Text] [Related]
26. The utility of tetraspanin CD9 as a biomarker for metastatic clear cell renal cell carcinoma.
Garner JM; Herr MJ; Hodges KB; Jennings LK
Biochem Biophys Res Commun; 2016 Feb; 471(1):21-5. PubMed ID: 26855131
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
28. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
29. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
[TBL] [Abstract][Full Text] [Related]
31. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
[TBL] [Abstract][Full Text] [Related]
32. Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma.
Islam AH; Ehara T; Kato H; Hayama M; Kobayashi S; Igawa Y; Nishizawa O
J Urol; 2004 Mar; 171(3):1319-23. PubMed ID: 14767341
[TBL] [Abstract][Full Text] [Related]
33. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
34. Cadherins in renal cell carcinoma.
Heicappell R
Anticancer Res; 1999; 19(2C):1501-4. PubMed ID: 10365132
[TBL] [Abstract][Full Text] [Related]
35. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
36. Reduced expression of E-cadherin and increased sialylation level in clear cell renal cell carcinoma.
Borzym-Kluczyk M; Radziejewska I; Cechowska-Pasko M; Darewicz B
Acta Biochim Pol; 2017; 64(3):465-470. PubMed ID: 28742884
[TBL] [Abstract][Full Text] [Related]
37. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
[TBL] [Abstract][Full Text] [Related]
38. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
Xu L; Jiang Y; Zheng J; Xie G; Li J; Shi L; Fan S
Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
